Pilot trial to assess cognitive function changes in Rett Syndrome during Trofinetide treatment
A pilot trial will evaluate cognitive function changes in Rett Syndrome patients during Trofinetide treatment using eye-tracking measures.
Indication
Clinical and regulatory intelligence for Rett Syndrome with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.